In the recent decades the number of myocardial revascularization procedures, incorporating coronary angioplasty, in chronic stable angina (CSA) patients has grown significantly. Irrespective of various innovations in coronary angioplasty techniques that require coronary stent grafts, recurrent angina post coronary angioplasty has become a frequent medical issue that many cardiologists in clinical practice have to face. The plight has turned so worse that over 30% of patients with prior revascularization still report issues associated with angina in follow-up time periods, which could increase the demand for cardiac medical treatments, which usually include coronary stent grafts. Furthermore, the growing number of ambulatory surgical centers, hospitals, medical facilities, and emergency rooms, etc. continue to increase sale prospects of coronary stent grafts, with each one of them needing the medical equipment required to perform treatment of severe perforation or rupture of coronary arteries and aneurysm of coronary arteries, etc.
A recent vital interventional cardiology prediction made by American College of Cardiology (ACC) and Transcatheter Cardiovascular Therapeutics (TCT) meetings indicates eventual monopoly of bioresorbable stents in the forthcoming years, which is expected to bring tremendous changes in the manufacturing of coronary stent grafts market, prompting the makers of coronary stent grafts to explore enhanced bioreasorable solution to be able to meet the changing needs of the medical practices.
Furthermore, coronary stent grafts market may remain highly influenced by the diverse rapidly-changing percutaneous coronary intervention (PCI) regulations, for example, the existing US guidelines don’t endorse elective PCI in facilities in the absence of on-site surgical back-up, which could impact coronary stent grafts market.
Stents are small expandable tubes used to treat narrowed or weakened arteries in the body. In patients with coronary artery disease (CAD), coronary stents are used to open narrowed arteries and also help in reducing symptoms, such as chest pain (angina), as well as in the treatment of heart attack. Coronary stent grafts are used for transluminal implantation in coronary arteries or aorto-coronary bypass grafts for the treatment of acute perforation or rupture of coronary arteries as well as aneurysm of coronary arteries or coronary bypass-vein graft. Coronary stents are implanted in narrowed coronary arteries during a procedure called the percutaneous coronary intervention (PCI) or angioplasty.
Coronary stent grafts are of various types, such as Bio-Vascular Scaffold (BVS), Bio-engineered Stent, Drug Eluting Stents (DES), Bare metal stents and Dual Therapy Stent (DTS). These different types of stents are used for various different purposes. The Bio-Vascular Scaffold (BVS) is a drug eluting stent on a dissolvable type of scaffold platform which can be absorbed by the body over time. A Bio-engineered Stent (antibody-coated stent), on the other hand, helps in speed up the cell lining of the artery (endothelialization), thereby promoting natural healing. The Drug Eluting Stents (DES) are coated with medication that is released (eluted) to help prevent the growth of scar tissue in the artery lining. This type of stent helps the artery to remain smooth and open, thereby ensuring good blood flow and reducing the chances of artery re-narrowing or restenosis. Bare metal stents are usually made from stainless steel and have no special coating.
Dual Therapy Stent (DTS) is the latest type of coronary stent. It is a first-of-its-kind stent therapy that reduces any likelihood of the re-narrowing of the artery as well as helps in the healing of the artery. It combines the benefit of DES with the benefits of bio-engineered stents and is the only stent to contain a drug with an active healing technology. These types of stents are usually made of metal mesh and are commonly called heart stents or cardiac or coronary stents.
Coronary Stent Grafts Market: Drivers and Restraints
Growing cases of coronary angioplasty (a treatment to widen narrowed sections of coronary arteries) is one of the key factors driving the demand for coronary stent grafts in hospitals, surgical centers and emergency rooms. The growth in the number of patients suffering from angina is leading to growth in demand for coronary angioplasty, which is driving the coronary stent graft market. Besides, due to less surgery time and low cost of surgery as compared to bypass surgery, coronary angioplasty is highly favored. The average cost of the Minimally Invasive Coronary Bypass Surgery in India is approximately $7000 whereas the cost of angioplasty in India for a single stent is around $ 2,745. However, the side effects associated with coronary angioplasty (PCI) might hamper its adoption rate. It has been observed that PCI itself tends to injure the artery walls and increases the risk of secondary obstruction. In fact, 21% of the PCI group required another stent within six months while 60% of the treated vessels required re-stenting. Thus, this factor is expected to restrict the growth of the coronary stent grafts market during the forecast period.
Coronary Stent Grafts Market: Segmentation
The global coronary stent grafts market can be segmented on the basis of type, material and end users.
Based on type, the global coronary stent grafts market is segmented as:
- Dual Therapy Stent (DTS)
- Bioresorbable Vascular Scaffold (BVS)
- Bio-engineered Stent
- Drug Eluting Stent (DES)
- Bare Metal Stent (BMS)
Based on material, the global coronary stent grafts market is segmented as:
Based on end users, the global coronary stent grafts market is segmented as:
- Ambulatory Surgical Centers
- Emergency Rooms
Coronary Stent Grafts Market: Overview
The global market for coronary stent grafts is expected to witness moderate growth over the forecast period. Metal coronary stent grafts are expected to be a dominant segment in the global coronary stent grafts market over the forecast period. Among all different types of coronary stent grafts, bioresorbable vascular scaffold type to hold significant share in the global coronary stent grafts market. The hospitals end-use segment is expected to contribute high share owing to increasing cases of patients suffering from angina.
Coronary Stent Grafts Market: Regional Outlook
Geographically, the global coronary stent grafts market is segmented into the following regions: North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to dominate the global coronary stent grafts market owing to growing number of patients suffering from cardiac or artery related disorders as well as the technological advancements taking place in the coronary stent grafts market. Europe to hold the second largest share in the coronary stent grafts market owing to direct presence of key manufacturers in Western as well as Eastern Europe. However, the market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to gradually increasing patient pool, low surgery cost in Asian countries, medical tourism and growing geographical reach of major players.
Coronary Stent Grafts Market: Key Participants
The global market for coronary stent grafts is a highly consolidated market. This market is specifically dominated by key players, such as Bentley Innomed GmbH, Abbott, Vascular Concepts and InSitu Technologies® Inc.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
- Middle East and Africa (GCC, S. Africa, Rest of MEA)
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Benefits of Becoming a Fact.MR Client
- Access to our global market coverage
- Periodic updates on your sector
- Exclusive discounts and offers
- Greater flexibility for customization
- Quick-research assistance for ad-hoc needs
- Access to credible insights Fact.MR analyst interactions
- Access to Fact.MR tools and research to fuel strategy development